These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 8923812)
1. Main ginseng saponin metabolites formed by intestinal bacteria. Hasegawa H; Sung JH; Matsumiya S; Uchiyama M Planta Med; 1996 Oct; 62(5):453-7. PubMed ID: 8923812 [TBL] [Abstract][Full Text] [Related]
2. Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Hasegawa H; Sung JH; Benno Y Planta Med; 1997 Oct; 63(5):436-40. PubMed ID: 9342949 [TBL] [Abstract][Full Text] [Related]
3. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Lee BH; Lee SJ; Hur JH; Lee S; Sung JH; Huh JD; Moon CK Planta Med; 1998 Aug; 64(6):500-3. PubMed ID: 9741293 [TBL] [Abstract][Full Text] [Related]
4. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Wakabayashi C; Hasegawa H; Murata J; Saiki I Oncol Res; 1997; 9(8):411-7. PubMed ID: 9436194 [TBL] [Abstract][Full Text] [Related]
5. Acylated protopanaxadiol-type ginsenosides from the root of Panax ginseng. Zhu GY; Li YW; Hau DK; Jiang ZH; Yu ZL; Fong WF Chem Biodivers; 2011 Oct; 8(10):1853-63. PubMed ID: 22006713 [TBL] [Abstract][Full Text] [Related]
6. [Isolation and identification of minor bioactive saponins from the leaves of Panax notoginseng]. Jiang B; Wang C; Han Y; Hu X; Zheng L; Zhao Y Zhong Yao Cai; 2004 Jul; 27(7):489-91. PubMed ID: 15551962 [TBL] [Abstract][Full Text] [Related]
7. Antimetastatic efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite. Hasegawa H; Uchiyama M Planta Med; 1998 Dec; 64(8):696-700. PubMed ID: 9933987 [TBL] [Abstract][Full Text] [Related]
8. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats. Karikura M; Miyase T; Tanizawa H; Taniyama T; Takino Y Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2357-61. PubMed ID: 1804549 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Sun J; Hu S; Song X Vaccine; 2007 Jan; 25(6):1114-20. PubMed ID: 17069940 [TBL] [Abstract][Full Text] [Related]
10. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Karikura M; Miyase T; Tanizawa H; Takino Y; Taniyama T; Hayashi T Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2859-61. PubMed ID: 2076572 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of a biologically active fluorescent derivative of GM1, a main Ginseng saponin metabolite formed by intestinal bacteria. Hasegawa H; Suzuki R; Wakabayashi C; Murata J; Tezuka Y; Saiki I; Kadota S Biol Pharm Bull; 1998 May; 21(5):513-6. PubMed ID: 9635509 [TBL] [Abstract][Full Text] [Related]
12. In vitro biotransformation of red ginseng extract by human intestinal microflora: metabolites identification and metabolic profile elucidation using LC-Q-TOF/MS. Wang HY; Hua HY; Liu XY; Liu JH; Yu BY J Pharm Biomed Anal; 2014 Sep; 98():296-306. PubMed ID: 24973593 [TBL] [Abstract][Full Text] [Related]
13. Analysis of ginsenosides by chromatography and mass spectrometry: release of 20 S-protopanaxadiol and 20 S-protopanaxatriol for quantitation. Cui JF; Garle M; Lund E; Björkhem I; Eneroth P Anal Biochem; 1993 May; 210(2):411-7. PubMed ID: 8512077 [TBL] [Abstract][Full Text] [Related]
14. Transglycosylation to ginseng saponins by cyclomaltodextrin glucanotransferases. Kim YH; Lee YG; Choi KJ; Uchida K; Suzuki Y Biosci Biotechnol Biochem; 2001 Apr; 65(4):875-83. PubMed ID: 11388467 [TBL] [Abstract][Full Text] [Related]
15. Biotransformation and metabolic profile of American ginseng saponins with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry. Wan JY; Liu P; Wang HY; Qi LW; Wang CZ; Li P; Yuan CS J Chromatogr A; 2013 Apr; 1286():83-92. PubMed ID: 23499252 [TBL] [Abstract][Full Text] [Related]
16. Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic method. Ko SR; Suzuki Y; Suzuki K; Choi KJ; Cho BG Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1522-7. PubMed ID: 17917300 [TBL] [Abstract][Full Text] [Related]
17. [Water-soluble ginsenosides in American ginseng]. Zhou Y; Song F; Liu S; Li X Zhongguo Zhong Yao Za Zhi; 1998 Sep; 23(9):551-2, inside back cover. PubMed ID: 11599389 [TBL] [Abstract][Full Text] [Related]
18. Combination of HPLC and 252-Cf plasma desorption mass spectrometry for identifying composition of ginseng tinctures. Elkin YN; Makhankov VV; Uvarova NL; Bondarenko PV; Zubarev RA; Knysh AN Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):97-100. PubMed ID: 8352021 [TBL] [Abstract][Full Text] [Related]
19. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Bae EA; Han MJ; Kim EJ; Kim DH Arch Pharm Res; 2004 Jan; 27(1):61-7. PubMed ID: 14969341 [TBL] [Abstract][Full Text] [Related]
20. Antiallergic activity of ginseng and its ginsenosides. Choo MK; Park EK; Han MJ; Kim DH Planta Med; 2003 Jun; 69(6):518-22. PubMed ID: 12865969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]